CD14 and Parkinson disease: We found an altered monocyte subpopulation in PD patients with, on average, a higher frequency of total CD14 + monocytes and a higher frequency of monocytes expressing the CCR2 receptor for monocyte chemoattractant protein‐1 (MCP‐1 or CCL2).